Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ross Miller

Public Health & General Preventive Medicine Beverly Hills, CA Medical Doctor

NPI 1134209794 CMS profile 1221214

9100 Wilshire Blvd Ste 655E, Beverly Hills, CA 90212

Open in the dashboard

General payments

$64,968

99 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ross Miller of Beverly Hills, CA is reported in the CMS Open Payments database as having received $64,968 across 99 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Public Health & General Preventive Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,782 5
2024 General $10,363 13
2023 General $10,804 15
2022 General $5,653 11
2021 General $14,631 9
2020 General $4,447 22
2019 General $13,288 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ross Miller
  • Public Health & General Preventive Medicine median
  • Middle half of Public Health & General Preventive Medicine
  • National median

In program year 2025, general payments to Ross Miller were reported at $5,782. Among 185 Public Health & General Preventive Medicine profiles paid that year, the median was $99 and the middle half received between $32 and $365.

Show as a table
Year Ross Miller Public Health & General Preventive Medicine median Middle half National median
2019 $13,288 $99 $22–$287 $163
2020 $4,447 $101 $21–$478 $114
2021 $14,631 $99 $31–$856 $132
2022 $5,653 $79 $24–$340 $149
2023 $10,804 $102 $28–$326 $160
2024 $10,363 $98 $27–$291 $164
2025 $5,782 $99 $32–$365 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $10,528 7 payments
  2. Novo Nordisk Inc $8,018 29 payments
  3. Gilead Sciences, Inc. $7,400 2 payments
  4. Boehringer Ingelheim International GmbH $6,250 2 payments
  5. Gen-Probe, Inc. $5,761 4 payments
  6. Vertex Pharmaceuticals Incorporated $5,200 1 payment
  7. Alkermes, Inc. $5,061 4 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $4,942 4 payments
  9. Biogen, Inc. $3,710 2 payments
  10. Shield Therapeutics Inc $3,194 4 payments
  11. Other $4,905 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $39,640 15 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,582 7 payments
  3. Travel and Lodging $5,875 9 payments
  4. Food and Beverage $2,888 52 payments
  5. Honoraria $1,500 1 payment
  6. Education $484 15 payments
Products named General payments · program years 2019–2025
  1. Aptima $3,602 4 payments
  2. ACCRUFER $3,194 4 payments
  3. NONE $2,500 1 payment
  4. SPINRAZA $1,750 1 payment
  5. Non-Covered Product $1,575 1 payment
  6. GEMTESA $1,075 3 payments
  7. BTX $542 2 payments
  8. HYDROXYCHLOROQUINE SULFATE $350 1 payment
  9. DUPIXENT $203 6 payments
  10. Victoza $161 5 payments
  11. Other $1,914 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

99 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Public Health & General Preventive Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record